Dr. François Gros-Louis is a regular researcher at the CHU Research Center of Québec-Laval University and Professor in the Department of Surgery of the School of Medicine at Laval University. Dr. Gros-Louis’ research activities are grouped together at the Multidisciplinary Center for Tissue Engineering (LOEX), a research center dedicated to organogenesis, stem cells, regenerative medicine and to the reconstruction of living human tissues and organs through tissue engineering. He holds the Canada Research Chair in Biomodeling and Treatment of Brain Diseases, and is the co-director of the induced pluripotent stem cell platform (iPSC).

Several neurological conditions such as neurodegenerative diseases and other brain diseases occupy a prominent place because of their severity and increasing frequency related to the aging of the population. One of the major obstacles to understanding the development of these diseases is the accessibility of neuronal tissues. Dr. Gros-Louis’ research, at the crossroads between basic research and clinical research, is positioned in a fast-growing research field that aims to reconstruct human tissue through tissue engineering, using patient-derived tissue, to model and better understand the pathophysiological mechanisms underlying these diseases. The main objective of his research program is to reconstruct by tissue engineering, from the patient’s own cells, organs / organoids (skins and blood vessels) whose histological, physiological and functional properties make it possible to reproduce the pathological signatures of various brain diseases (Amyotrophic Lateral Sclerosis (ALS), intracranial aneurysm and neurofibromatosis). The specific objectives are: 1) to identify new strategies for early diagnosis, 2) to study and monitor the progression of targeted diseases, 3) to evaluate the response to existing and future treatments, 4) to identify and understand pathogenic mechanisms, and 5) to identify specific biomarkers and to develop new therapeutic pathways. Dr. Gros-Louis has played a major role in the discovery and application of a novel method for the in vitro reconstruction of tissue, through tissue engineering, for the study of ALS, neurofibromatosis, and intracranial aneurysms.

1401, 18e Rue
LOEX / CMDGT
R-211
Québec, Québec
Canada G1J 1Z4
52 entries « 2 of 6 »

Clément V, Roy V, Paré B, Goulet CR, Deschênes LT, Berthod F, Bolduc S, Gros-Louis F

Tridimensional cell culture of dermal fibroblasts promotes exosome-mediated secretion of extracellular matrix proteins

Journal Article

Sci Rep, 12 (1), 2022.

Abstract | Links:

Desjardins P, Berthiaume R, Couture C, Le-Bel G, Roy V, Gros-Louis F, Moulin VJ, Proulx S, Chemtob S, Germain L, Guérin SL

Impact of Exosomes Released by Different Corneal Cell Types on the Wound Healing Properties of Human Corneal Epithelial Cells

Journal Article

Int J Mol Sci, 23 (20), 2022.

Abstract | Links:

Bussiere N, Mei J, Levesque-Boissonneault C, Blais M, Carazo S, Gros-Louis F, Laforce R, De Serres G, Dupre N, Frasnelli J

Persisting chemosensory impairments in 366 healthcare workers following COVID-19: an 11-month follow-up

Journal Article

Chem Senses, 47 , 2022.

Abstract | Links:

Bchetnia M, Martineau L, Racine V, Powell J, McCuaig C, Morin C, Dupérée A, Gros-Louis F, Laprise C

Generation of three induced pluripotent stem cell lines (UQACi003-A, UQACi004-A, and UQACi006-A) from three patients with KRT5 epidermolysis bullosa simplex mutations

Journal Article

Stem Cell Res, 60 , 2022.

Abstract | Links:

Roy V, Ross JP, Pépin R, Cortez Ghio S, Brodeur A, Touzel Deschênes L, Le-Bel G, Phillips DE, Milot G, Dion PA, Guérin S, Germain L, Berthod F, Auger FA, Rouleau GA, Dupré N, Gros-Louis F

Moyamoya Disease Susceptibility Gene RNF213 Regulates Endothelial Barrier Function

Journal Article

Stroke, 53 (4), 2022.

Abstract | Links:

Bchetnia M, Martineau L, Racine V, Powell J, McCuaig C, Morin C, Dupérée A, Gros-Louis F, Laprise C

Generation of two induced pluripotent stem cell lines (UQACi002-A and UQACi005-A) from two patients with KRT14 epidermolysis bullosa simplex mutations

Journal Article

Stem Cell Res, 61 , 2022.

Abstract | Links:

Tremblay K, Rousseau S, Zawati MH, Auld D, Chassé M, Coderre D, Falcone EL, Gauthier N, Grandvaux N, Gros-Louis F, Jabet C, Joly Y, Kaufmann DE, Laprise C, Larochelle C, Maltais F, Mes-Masson AM, Montpetit A, Piché A, Richards JB, Tse SM, Turgeon AF, Turecki G, Vinh DC, Wang HT, Mooser V,

The Biobanque québécoise de la COVID-19 (BQC19)-A cohort to prospectively study the clinical and biological determinants of COVID-19 clinical trajectories

Journal Article

PLoS One, 16 (5), 2021.

Abstract | Links:

Roy V, Lamontagne R, Talagas M, Touzel-Deschenes L, Khuong HT, Saikali S, Dupre N, Gros-Louis F

Biofabrication of a three dimensional human-based personalized neurofibroma model

Journal Article

Biotechnol J, 16 (6), 2021.

Abstract | Links:

Bussière N, Mei J, Lévesque-Boissonneault C, Blais M, Carazo S, Gros-Louis F, De Serres G, Dupré N, Frasnelli J

Chemosensory Dysfunctions Induced by COVID-19 Can Persist up to 7 Months: A Study of Over 700 Healthcare Workers

Journal Article

Chem Senses, 46 , 2021.

Abstract | Links:

Martel C, Tsutsumi T, Cement V, Khuong HT, Dupre N, Ismail AA, Gros-Louis F

Diagnosis of idiopathic amyotrophic lateral sclerosis using Fourier-transform infrared spectroscopic analysis of patient-derived skin

Journal Article

Analyst, 145 (10), 2020.

Abstract | Links:

52 entries « 2 of 6 »
Signaler des ajouts ou des modifications

Active projects

  • Chaire de recherche du Canada en génie tissulaire et modélisation 3D des maladies du cerveau, from 2023-05-01 to 2030-04-30
  • Depicting disease heterogeneity in neurofibromatosis type 1 and the role of dermal fibroblasts in the establishment of microenvironment favouring NF1-associated skin tumor formation using personalized tissue-engineered 3D models, from 2023-10-01 to 2028-09-30
  • Organogenèse de muqueuse nasale autologue pour la reconstruction endoscopique endonasale en chirurgie de la base du crâne, from 2023-10-01 to 2028-09-30

Recently finished projects

  • Chaire de recherche du Canada en biomodélisation et traitement des maladies du cerveau, from 2017-11-01 to 2022-10-31
  • Chaire de recherche sur les organes reconstruits en laboratoire et leurs applications cliniques, from 2013-05-01 to 2023-12-01
  • Conversion directe de fibroblastes en cellules de Schwann pour stimuler la réparation des nerfs périphériques, from 2022-04-01 to 2023-03-31
  • Creating an Open Science Repository of ARCA1 iPSCs, from 2021-05-31 to 2023-05-31
  • Depicting disease heterogeneity in neurofibromatosis type 1 and the role of microenvironment in NF1-associated skin tumor formation through personalized tissue-engineered 3D models, from 2023-03-01 to 2024-02-29
  • Design and testing of a next-generation tissue-engineered living human heart valve, from 2020-03-31 to 2023-03-31
  • Génie tissulaire et modélisation 3D des maladies du cerveau, from 2023-04-01 to 2024-03-31
  • Les cellules souches pluripotentes génétiquement corrigées comme thérapie pour l’epidermolyse bulleuse simplex, from 2022-04-01 to 2023-03-31
  • Renforcement de la plateforme de production de cellules souches induites à la pluripotence (IPSC) du CRCHU de Québec, from 2019-12-05 to 2023-03-31
Data provided by the Université Laval research projects registery